The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, [2] the Sinopharm COVID-19 vaccine, [3] or BIBP vaccine, [3] [4] [5] is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products (sometimes written as Beijing Bio-Institute of Biological Products, [6] resulting in the two ...

2022年6月10日 · The Sinopharm vaccine can be offered to people who have had COVID-19 in the past. But individuals may choose to delay vaccination for 3 months following the infection. Should pregnant and breastfeeding women be vaccinated?

2022年6月3日 · This vaccine resource provides key vaccine-specific information for the Sinopharm COVID-19 vaccine (vero cell) inactivated vaccine against coronavirus disease 2019 (COVID-19). This document has been updated in English: version 03 June 2022.

2021年6月21日 · China has administered more than one billion doses of its homegrown COVID-19 vaccines, the majority of which were developed by local companies Sinovac and Sinopharm. So what do we know about...

The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for the use of the inactivated COVID-19 vaccine BIBP developed by Sinopharm/China National Pharmaceutical Group. Here is what you need to know.

The SARS-CoV-2 Vaccine (VeroCell) is an inactivated vaccine against coronavirus disease 2019 (COVID-19) which stimulates the body’s immune system without risk of causing disease.

The Sinopharm WIBP COVID-19 vaccine, also known as WIBP-CorV, [2] [3] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. Peer-reviewed results show that the vaccine is 72.8% effective against symptomatic cases and 100% against severe cases (26 cases in vaccinated group vs. 95 cases in placebo group). [ 4 ]

2021年5月7日 · The World Health Organization (WHO) has granted emergency approval for a Covid vaccine made by Chinese state-owned company Sinopharm. It is the first vaccine developed by a non-Western country...

2021年7月13日 · Chinese vaccine producers Sinovac and Sinopharm have signed on to global vaccine sharing scheme Covax, which aims to distribute vaccines to poorer countries. The Global Alliance for Vaccines...

2020年12月30日 · January, 2020 Sinopharm begins developing an inactivated vaccine against the coronavirus. June Researchers report the vaccine produces promising results in monkeys. A Phase 1/2 trial shows...